The university is arguing that the judge had no basis to compel arbitration of what Cornell is claiming is a fraudulent settlement.
Cornell claims that it was fraudulently induced into settling a patent-infringement lawsuit it filed with Life Tech against Illumina.
The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.
In PLOS this week: plague patterns in Kyrgyzstan, trypanosomiasis susceptibility variants, and more.
Among the winners are a number of investigators who will receive funding to support omics-focused research.
The funding will support three research centers and a data management and coordinating center investigating myalgic encephalomyelitis/chronic fatigue syndrome.
The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.
Genetically modified diamondback moths are being tested in upstate New York, according to the Atlantic.
The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.
Gene drives might run into biological resistance, the Economist reports.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.